GIZUMOJapan TechnologyPrivate preview
Chugai Pharmaceutical Co. — company logo
Tokyo · Kanto

Chugai Pharmaceutical Co.

中外製薬

What the record establishes

Wikidata records this company as “Chugai Pharmaceutical Co.”, described as “Switzerland company in Japan”. The record dates its founding to 1925. Its headquarters is recorded in Tokyo. The record reports 6,872 employees. The item is Q750619 in Wikidata’s CC0 structured data, checked 2026-11-18. The record classifies it as: business, enterprise, public company.

The record does not carry product catalogues or financial results, and this profile does not invent them. What can be checked is the record itself, linked below.

About Chugai Pharmaceutical Co.

Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.

History

Timeline

This is a timeline of important events of Chugai Pharmaceutical.

1925: Juzo Ueno founded Chugai Shinyaku Co. Ltd. and started importing and selling medicines

1927: Start of the first own production

1930: Salobrocanon, an analgesic (pain reliever ) and antipyretic, is launched

1937: Calcium bromide production begins

1943: Name changed to Chugai Pharmaceutical Co., Ltd. based in Tokyo

1944: Acquisition of Matsunaga Pharmaceutical Ltd. and construction of a plant in Matsunaga

1945: The headquarters, the factories in Ikebukuro, Sakai and Takada were destroyed in World War II, the headquarters were relocated to Takada, the factory in Takada was rebuilt

1946: Construction of the plant in Kamagiishi

1951: Guronsan, a drug to detoxify and restore liver function, is launched

1952: Varsan, a perspiration insecticide, is launched

1955: Chugai became a public company.

1956: The stock is listed on the Tokyo Stock Exchange

1957: Construction of the Ukima plant

1960: Establishment of a research center (Takada Research Laboratory, Tokyo)

1967: Foundation of Fukushima Kasai Co Ltd.

1961 – Developed patents for synthesis of vitamin A

1969: The name of Fukushima Kasai Co Ltd. is changed to Eiko Kasei Co Ltd., after the merger of Fukushima Kasai Co Ltd. and Fukuma Kasau Co. Ltd.

1971: Construction of the factory in Fujieda

1975: Picibanil, a cancer drug, is launched

1982: Opening of a branch in New York

1986: Opening of a branch in London

1989: Acquisition of Gen-Probe Incorporated (USA)

1990: Epogin launched

1995 – Released acute promyelocytic sphere of leukemia drug treatment Vesanoid

1996 – Released anti-viral chemotherapeutic agent Hivid (HIV reverse transcriptase inhibitor)

1997 – Released HIV protease inhibitor Invirase

1999 – Released immunosuppressive agent Cellcept

2000 – Released antiemetic drug Kytril, developed to combat the side effects of chemotherapy

2001 – Produced anti-influenza virus Tamiflu (Roche)

2002: Start of the alliance with Roche

2003: Xeloda, a cancer drug, is launched

2005: Actemra launched

2007: Copegus, an antiviral, Avastin, a cancer drug, and Tarceva, a cancer drug launched

2011 – Produced Actemra, a human IL-6 receptor monoclonal antibody for rheumatoid arthritis

2014: Launch of Kadcyla, a cancer drug, Chugai Pharma China Co Ltd. founded

2015 – In March the company announced it would co-commercialise Athersys's stem cell therapy for ischemic strokes in Japan. The deal could yield upwards of US$205 million.

2016: Cooperation between Osaka University and Chugai

2018: Tecentriq, a cancer drug, is launched

2020 – FDA approved satralizumab (Enspryng) for treatment of the orphan disease neuromyelitis optica

Text adapted from Wikipedia (“Chugai”), published under CC BY-SA 4.0. Source article

At a glance

  • Typebusiness, enterprise, public company
  • Founded1925
  • HeadquartersTokyo
  • Employees6,872
  • Listed onTokyo Stock Exchange (4519)
  • Official websitehttps://www.chugai-pharm.co.jp

About the logo

The image on this page is the company’s logo as held by Wikimedia Commons, file “Chugai Pharmaceutical.svg”, credited to Chugai Pharmaceutical Vectorization: Kopiersperre and published under Public domain. A logo is shown because it belongs to this company by definition; no photograph is used unless the Commons record itself ties the photograph to this company.

Planning from the record

The record carries an official website, linked below. Products, offices and contact details change, so treat that site — not this profile — as the current source. This profile is built from open records and does not establish today’s operating state.

Sources and next steps

Original English profile generated from Wikidata and Wikimedia Commons records · Sources reviewed 18 November 2026. Operational details can change.

  • DiscoverSwitzerland company in Japan
  • NoticeFounded: 1925
  • RememberTokyo

Exhibits and access can change. This preview does not offer product procurement, commercial specifications or live visitor information.

Chugai Pharmaceutical Co. — company logo Chugai Pharmaceutical Vectorization: Kopiersperre · Public domain · Photo details

Official source · Source checked 2026-11-18 · Original English profile